Our Company

Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care.

Our patented system enables healthcare professionals to access actionable, laboratory-quality results at the point-of-care with greater sensitivity and specificity than current infectious disease rapid immunoassay tests.

Our Goal

We strive to bring DNA and RNA testing to a much larger population segment than alternative, legacy solutions so healthcare providers can more effectively treat patients.

Our Technology

Our proprietary OSCAR technology is key to our patented and patent-pending diagnostic solutions. Our revolutionary technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity, specificity of laboratory-based molecular testing.

Executive Team

Hong Cai  Co-Founder & Chief Executivie Officer    Dr. Hong Cai leads Mesa Biotech, having co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-based assays for forensic analysis, biothreat pathogen detection, and human disease diagnosis.

Hong Cai
Co-Founder & Chief Executivie Officer

Dr. Hong Cai leads Mesa Biotech, having co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-based assays for forensic analysis, biothreat pathogen detection, and human disease diagnosis.

R. Bruce Cary  Co-Founder & Chief Scientific Officer    Dr. Cary is a co-found of Mesa Biotech and the inventor of the technology that is the basis of the company’s platform. As CSO, he leads projects for the development of rapid molecular tests. Previously he spent 13 years as a principal investigator and scientist at Los Alamos National Laboratory, leading projects focused on biodefense, pathogen detection, nucleic acid metabolism and microarray gene expression technology.

R. Bruce Cary
Co-Founder & Chief Scientific Officer

Dr. Cary is a co-found of Mesa Biotech and the inventor of the technology that is the basis of the company’s platform. As CSO, he leads projects for the development of rapid molecular tests. Previously he spent 13 years as a principal investigator and scientist at Los Alamos National Laboratory, leading projects focused on biodefense, pathogen detection, nucleic acid metabolism and microarray gene expression technology.

Tom Willardson  Chief Financial Officer    Tom Willardson brings 30+ years of finance related experience including 3 successful IPOs and small and large capital raises in a variety of industries. Tom previously was Former CFO of Sapphire Energy, Aurora Algae, Energy Recovery, Cost Plus World Market, and WebSideStory

Tom Willardson
Chief Financial Officer

Tom Willardson brings 30+ years of finance related experience including 3 successful IPOs and small and large capital raises in a variety of industries. Tom previously was Former CFO of Sapphire Energy, Aurora Algae, Energy Recovery, Cost Plus World Market, and WebSideStory

 
John Monroe  Chief Operations Officer    John Monroe brings 30+ years of experience in operations, manufacturing, process development, procurement and inventory management in the IVD industry. He is a healthcare industry veteran having lead teams at companies that include Alere, Dako, and Quidel.

John Monroe
Chief Operations Officer

John Monroe brings 30+ years of experience in operations, manufacturing, process development, procurement and inventory management in the IVD industry. He is a healthcare industry veteran having lead teams at companies that include Alere, Dako, and Quidel.

Steven Sepulveda  Vice President of Global Business Development & Channel Management    With over 28 years of In Vitro Diagnostics experience, Steven brings leadership, strategy development and commercial expertise across the healthcare continuum both domestic and international. Previously, he held leadership roles at Sekisui Diagnostics, Horiba Medical, Beckman Coulter, Quidel and also served on the Board of Directors of the Health Industry Distributors Association (HIDA) Educational Foundation.

Steven Sepulveda
Vice President of Global Business Development & Channel Management

With over 28 years of In Vitro Diagnostics experience, Steven brings leadership, strategy development and commercial expertise across the healthcare continuum both domestic and international. Previously, he held leadership roles at Sekisui Diagnostics, Horiba Medical, Beckman Coulter, Quidel and also served on the Board of Directors of the Health Industry Distributors Association (HIDA) Educational Foundation.

Don Thomas  Vice President of Engineering & Product Development    Don Thomas leverages 25+ years of experience in Product Development to lead Mesa Biotech engineering and R&D efforts. He has a successful track record leading cross-disciplinary teams in development of both molecular and cell-based assay systems. Previously, he held senior leadership positions at ACEA Biosciences and Nanogen.

Don Thomas
Vice President of Engineering & Product Development

Don Thomas leverages 25+ years of experience in Product Development to lead Mesa Biotech engineering and R&D efforts. He has a successful track record leading cross-disciplinary teams in development of both molecular and cell-based assay systems. Previously, he held senior leadership positions at ACEA Biosciences and Nanogen.

 
Julie Richardson  Vice President of Quality Assurance     Julie Richardson leads the commitment to superior Quality Systems for Mesa Biotech with 20+ years of IVD, Clinical, and Pharma experience in the areas of Development, Manufacturing Technical Support, Validation, and Quality Systems. She held positions of increasing responsibilities at companies such as Hybritech, Gen-Probe, and Teva Pharmaceuticals.

Julie Richardson
Vice President of Quality Assurance

Julie Richardson leads the commitment to superior Quality Systems for Mesa Biotech with 20+ years of IVD, Clinical, and Pharma experience in the areas of Development, Manufacturing Technical Support, Validation, and Quality Systems. She held positions of increasing responsibilities at companies such as Hybritech, Gen-Probe, and Teva Pharmaceuticals.

Pam Fettu  Senior Director of Human Resources    Pam serves as Senior Director, Human Resources. She received a master’s degree in Human Resources and a bachelor’s in Health Sciences from Chapman University and has earned Senior Professional in Human Resources (SPHR). With over 20 years of experience within dynamic organizations, she finds innovative ways of creating opportunities that will holistically strengthen the overall Mesa Biotech workforce.

Pam Fettu
Senior Director of Human Resources

Pam serves as Senior Director, Human Resources. She received a master’s degree in Human Resources and a bachelor’s in Health Sciences from Chapman University and has earned Senior Professional in Human Resources (SPHR). With over 20 years of experience within dynamic organizations, she finds innovative ways of creating opportunities that will holistically strengthen the overall Mesa Biotech workforce.

 

Chairman of the Board

 
Artboard%2B12.jpg

William R Brody
Chairman of the Board

Dr. Brody’s achievements in biomedical engineering have led to his recognition by numerous national and international organizations. He is a national figure in efforts to encourage innovation and strengthen the U.S. economy through investments in basic research and education. Most recently, he has written and spoken extensively to promote a fuller discussion of health care reform.